{"id":"NCT00496730","sponsor":"Organon and Co","briefTitle":"A Multicenter, Randomized, Open Label Study to Evaluate the Lipid Lowering Efficacy and Safety of Vytorin® 10/20 vs. Atorvastatin 10mg in Hypercholesterolemia Patients With Metabolic Syndrome in Korea (0653A-129)(COMPLETED)","officialTitle":"A Multicenter, Randomized, Open Label Study to Evaluate the Lipid Lowering Efficacy and Safety of Vytorin® 10/20 vs. Atorvastatin 10mg in Hypercholesterolemia Patients With Metabolic Syndrome in Korea","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-07","primaryCompletion":"2008-08","completion":"2008-08","firstPosted":"2007-07-04","resultsPosted":"2009-11-17","lastUpdate":"2024-05-16"},"enrollment":256,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Hypercholesterolemia"],"interventions":[{"type":"DRUG","name":"simvastatin (+) ezetimibe","otherNames":["MK0653A","Vytorin®"]},{"type":"DRUG","name":"Comparator: atorvastatin","otherNames":["Lipitor®"]}],"arms":[{"label":"Vytorin®","type":"EXPERIMENTAL"},{"label":"atorvastatin","type":"ACTIVE_COMPARATOR"}],"summary":"Prevalence of metabolic syndrome in korea is increasing. There is no clinical trial targeting on such increasing populations like metabolic syndrome patients with Vytorin® in korea. Therefore this trial will help evaluate the lipid lowering effect of Vytorin® in asian population with metabolic syndrome.","primaryOutcome":{"measure":"Mean Percent Change of Low Density Lipoprotein-Cholesterol (LDL-C) From Baseline After 8 Weeks.","timeFrame":"Baseline and 8 Weeks","effectByArm":[{"arm":"Vytorin","deltaMin":-49.29,"sd":15.22},{"arm":"Atorvastatin","deltaMin":-38.05,"sd":12.28}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":5},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1},"commonTop":["Hypercholesterolaemia","High Density lipoprotein decreased","Hypertriglyceridaemia","Hepatic enzyme increased","Abdominal pain upper"]}}